Gypenoside XVII inhibits ox-LDL-induced macrophage inflammatory responses and promotes cholesterol efflux through activating the miR-182-5P/HDAC9 signaling pathway.

[1]  Jun Shen,et al.  miR-383-5p Regulated by the Transcription Factor CTCF Affects Neuronal Impairment in Cerebral Ischemia by Mediating Deacetylase HDAC9 Activity , 2022, Molecular Neurobiology.

[2]  Jing Wang,et al.  Cardioprotective effects of gypenoside XVII against ischemia/reperfusion injury: Role of endoplasmic reticulum stress, autophagy, and mitochondrial fusion fission balance , 2022, Phytotherapy research : PTR.

[3]  Peng Kong,et al.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention , 2022, Signal Transduction and Targeted Therapy.

[4]  Jian-ping Luo,et al.  Laminaria japonica Polysaccharide Suppresses Atherosclerosis via Regulating Autophagy-Mediated Macrophage Polarization. , 2022, Journal of agricultural and food chemistry.

[5]  J. Björkegren,et al.  Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype , 2021, The Journal of clinical investigation.

[6]  T. Sun,et al.  Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA-21-mediated PTEN/AKT/mTOR pathway , 2021, International journal of molecular medicine.

[7]  Guanwei Fan,et al.  Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE−/− Mice , 2020, Frontiers in Pharmacology.

[8]  Xiao-Hua Yu,et al.  LncRNA kcnq1ot1 promotes lipid accumulation and accelerates atherosclerosis via functioning as a ceRNA through the miR-452-3p/HDAC3/ABCA1 axis , 2020, Cell Death & Disease.

[9]  Xiao-Hua Yu,et al.  Biochanin A Mitigates Atherosclerosis by Inhibiting Lipid Accumulation and Inflammatory Response , 2020, Oxidative medicine and cellular longevity.

[10]  W. Shen,et al.  Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway , 2020, Cell cycle.

[11]  Jia Wen Liang,et al.  A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR‐30d‐5p/HDAC9 axis and the epithelial–mesenchymal transition , 2020, Molecular carcinogenesis.

[12]  Shujuan Sun,et al.  The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Dayuan Li,et al.  MiR-182-5p Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by ox-LDL Through Targeting PAPPA. , 2020, International heart journal.

[14]  Zhiwei Wu,et al.  Enhancing PPARγ  by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice. , 2020, Pharmacological research.

[15]  Minakshi Rana,et al.  Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation[S] , 2020, Journal of Lipid Research.

[16]  X. Shu,et al.  Gypenosides mediate cholesterol efflux and suppress oxidized LDL induced inflammation in retinal pigment epithelium cells. , 2020, Experimental eye research.

[17]  Liping Chang,et al.  Gypenoside A protects ischemia/reperfusion injuries by suppressing miR-143-3p level via the activation of AMPK/Foxo1 pathway. , 2019, BioFactors.

[18]  Xingxing Li,et al.  Butyrate protects against high‐fat diet‐induced atherosclerosis via up‐regulating ABCA1 expression in apolipoprotein E‐deficiency mice , 2019, British journal of pharmacology.

[19]  Tessa J. Barrett.  Macrophages in Atherosclerosis Regression , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[20]  Guibo Sun,et al.  Gypenoside XVII protects against myocardial ischemia and reperfusion injury by inhibiting ER stress–induced mitochondrial injury , 2019, Journal of ginseng research.

[21]  Changsheng Yan,et al.  Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  Tae Young Kim,et al.  Gynostemma Pentaphyllum Extract Ameliorates High-Fat Diet-Induced Obesity in C57BL/6N Mice by Upregulating SIRT1 , 2019, Nutrients.

[23]  Xi-Long Zheng,et al.  Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo. , 2019, Atherosclerosis.

[24]  P. Libby,et al.  Atherosclerosis , 2019, Nature Reviews Disease Primers.

[25]  Ling-Ping Zhu,et al.  Circulating miR-182-5p and miR-5187-5p as biomarkers for the diagnosis of unprotected left main coronary artery disease. , 2019, Journal of thoracic disease.

[26]  D. Tang,et al.  Research Progress on the Relationship between Atherosclerosis and Inflammation , 2018, Biomolecules.

[27]  Weiwei Jiang,et al.  miR-182-5p Attenuates High-Fat -Diet-Induced Nonalcoholic Steatohepatitis in Mice. , 2018, Annals of hepatology.

[28]  Jun Zhang,et al.  Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation , 2018, Journal of cellular and molecular medicine.

[29]  Ping Li,et al.  Tanshindiol C inhibits oxidized low-density lipoprotein induced macrophage foam cell formation via a peroxiredoxin 1 dependent pathway. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[30]  Li-Tao Yi,et al.  miR-124 antagonizes the antidepressant-like effects of standardized gypenosides in mice , 2018, Journal of psychopharmacology.

[31]  A. Orekhov,et al.  Mechanisms of foam cell formation in atherosclerosis , 2017, Journal of Molecular Medicine.

[32]  Guibo Sun,et al.  Gypenoside XVII Prevents Atherosclerosis by Attenuating Endothelial Apoptosis and Oxidative Stress: Insight into the ERα-Mediated PI3K/Akt Pathway , 2017, International journal of molecular sciences.

[33]  A. Orekhov,et al.  Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes. , 2015, International journal of cardiology.

[34]  G. Zhan,et al.  Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. , 2015, World journal of gastroenterology.

[35]  A. Tall,et al.  Cholesterol, inflammation and innate immunity , 2015, Nature Reviews Immunology.

[36]  J. Repa,et al.  Histone Deacetylase 9 Represses Cholesterol Efflux and Alternatively Activated Macrophages in Atherosclerosis Development , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[37]  Jonathan D. Smith.  New role for histone deacetylase 9 in atherosclerosis and inflammation. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[38]  Z. Qin,et al.  The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. , 2012, Atherosclerosis.

[39]  Mudit Gupta,et al.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. , 2011, Cell stem cell.

[40]  M. Turunen,et al.  Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors. , 2010, Cardiovascular research.

[41]  D. Rader,et al.  The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis This work was supported by P01-HL22633 from the NHLBI. Published, JLR Papers in Press, December 8, 2008. , 2009, Journal of Lipid Research.

[42]  Heather M. Alger,et al.  Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From Atherosclerosis , 2008, Circulation.

[43]  Paul T. Tarr,et al.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.

[44]  Robert V Farese,et al.  Plasma Cholesteryl Esters Provided by Lecithin:Cholesterol Acyltransferase and Acyl-Coenzyme A:Cholesterol Acyltransferase 2 Have Opposite Atherosclerotic Potential , 2004, Circulation research.

[45]  E. Olson,et al.  Histone Deacetylases 5 and 9 Govern Responsiveness of the Heart to a Subset of Stress Signals and Play Redundant Roles in Heart Development , 2004, Molecular and Cellular Biology.

[46]  J. Oram,et al.  Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. , 2002, Trends in molecular medicine.

[47]  K. Bornfeldt,et al.  Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. , 2002, Biochemical and biophysical research communications.

[48]  D. Shiffman,et al.  Oxidized Low Density Lipoprotein Exposure Alters the Transcriptional Response of Macrophages to Inflammatory Stimulus* , 2001, The Journal of Biological Chemistry.

[49]  M. Grunstein.  Histone acetylation in chromatin structure and transcription , 1997, Nature.

[50]  S. Daskalopoulou,et al.  Adiponectin and cholesterol efflux. , 2019, Metabolism: clinical and experimental.

[51]  P. Murray.  Macrophage Polarization. , 2017, Annual review of physiology.

[52]  B. Staels,et al.  Macrophage subsets in atherosclerosis , 2015, Nature Reviews Cardiology.

[53]  E. Olson,et al.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.

[54]  I. Adcock,et al.  Histone acetylation and histone deacetylation , 2002, Molecular biotechnology.